20230000018498--01-28Q1false0000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-290000018498us-gaap:RetainedEarningsMember2021-01-3000000184982022-05-012022-06-080000018498gco:JohnstonAndMurphyGroupSegmentMemberus-gaap:IntersegmentEliminationMember2022-01-302022-04-300000018498us-gaap:OperatingSegmentsMember2021-01-312021-05-010000018498gco:LicensedBrandsSegmentMember2022-01-302022-04-300000018498us-gaap:OperatingSegmentsMembergco:JourneysGroupSegmentMember2021-05-010000018498us-gaap:OperatingSegmentsMembergco:SchuhGroupSegmentMember2022-01-302022-04-300000018498us-gaap:TreasuryStockMember2022-01-2900000184982022-01-290000018498us-gaap:OperatingSegmentsMembergco:JourneysGroupSegmentMember2022-01-302022-04-300000018498us-gaap:CommonStockMember2022-04-300000018498gco:JohnstonAndMurphyGroupSegmentMemberus-gaap:OperatingSegmentsMember2022-01-302022-04-300000018498us-gaap:PreferredStockMember2021-01-312021-05-010000018498us-gaap:FairValueInputsLevel3Member2022-04-300000018498us-gaap:OperatingSegmentsMembergco:JohnstonAndMurphyGroupSegmentMember2021-05-0100000184982023-04-300000018498us-gaap:IntersegmentEliminationMember2021-01-312021-05-010000018498country:CA2022-04-300000018498us-gaap:RetainedEarningsMember2022-01-302022-04-300000018498gco:SchuhGroupSegmentMember2022-01-302022-04-300000018498us-gaap:RetainedEarningsMember2022-04-300000018498us-gaap:RetainedEarningsMember2021-05-010000018498us-gaap:OperatingSegmentsMembergco:JourneysGroupSegmentMember2021-01-312021-05-010000018498gco:RetailStoreAssetImpairmentsMembergco:JourneysGroupSegmentMember2021-01-312021-05-010000018498us-gaap:AdditionalPaidInCapitalMember2022-01-302022-04-300000018498us-gaap:RetainedEarningsMember2022-01-290000018498us-gaap:TrademarksMember2022-01-290000018498gco:WholesaleCostsOfDistributionMember2021-01-312021-05-010000018498us-gaap:IntersegmentEliminationMember2022-01-302022-04-300000018498us-gaap:AdditionalPaidInCapitalMember2022-04-300000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-05-0100000184982021-05-010000018498gco:SchuhGroupSegmentMember2021-01-312021-05-010000018498us-gaap:OperatingSegmentsMembergco:SchuhGroupSegmentMember2022-04-300000018498us-gaap:CommonStockMember2021-05-010000018498gco:LicensedBrandsSegmentMemberus-gaap:OperatingSegmentsMember2021-05-010000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-302022-04-300000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-300000018498gco:SchuhGroupSegmentMemberus-gaap:IntersegmentEliminationMember2022-01-302022-04-300000018498us-gaap:AdditionalPaidInCapitalMember2021-01-312021-05-010000018498gco:RetailStoreAssetImpairmentsMembergco:SchuhGroupSegmentMember2021-01-312021-05-010000018498gco:SamsungCTAmericaIncorporationMember2022-04-300000018498gco:ProfessionalFeesRelatedToActionsOfActivistShareholderMember2021-01-312021-05-010000018498us-gaap:AdditionalPaidInCapitalMember2021-05-010000018498us-gaap:CorporateNonSegmentMember2021-01-312021-05-010000018498gco:RetailOccupancyCostsMember2022-01-302022-04-300000018498us-gaap:PreferredStockMember2022-01-302022-04-300000018498gco:JohnstonAndMurphyGroupSegmentMemberus-gaap:OperatingSegmentsMember2022-04-300000018498gco:JohnstonAndMurphyGroupSegmentMember2022-01-302022-04-300000018498gco:JourneysGroupSegmentMember2021-01-312021-05-010000018498us-gaap:PreferredStockMember2021-05-010000018498gco:LicensedBrandsSegmentMember2022-01-290000018498us-gaap:IntersegmentEliminationMembergco:JourneysGroupSegmentMember2021-01-312021-05-010000018498us-gaap:CommonStockMember2022-01-290000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-312021-05-010000018498gco:RetailOccupancyCostsMember2021-01-312021-05-010000018498gco:SchuhGroupSegmentMemberus-gaap:IntersegmentEliminationMember2021-01-312021-05-010000018498gco:USRevolverBorrowingsMember2022-04-300000018498gco:JohnstonAndMurphyGroupSegmentMembergco:RetailStoreAssetImpairmentsMember2021-01-312021-05-010000018498us-gaap:TreasuryStockMember2022-04-300000018498gco:USRevolverBorrowingsMember2022-01-2900000184982022-06-080000018498us-gaap:OtherIntangibleAssetsMember2022-01-2900000184982021-01-3000000184982023-01-302023-04-300000018498us-gaap:CorporateNonSegmentMember2022-04-300000018498gco:RetailStoreAssetImpairmentsMember2022-01-302022-04-300000018498country:GB2022-04-300000018498us-gaap:AdditionalPaidInCapitalMember2022-01-290000018498us-gaap:OtherIntangibleAssetsMember2022-04-300000018498us-gaap:OperatingSegmentsMembergco:SchuhGroupSegmentMember2021-05-010000018498us-gaap:TreasuryStockMember2021-01-300000018498gco:WholesaleCostsOfDistributionMember2022-01-302022-04-300000018498us-gaap:CommonStockMember2021-01-300000018498us-gaap:OperatingSegmentsMembergco:JohnstonAndMurphyGroupSegmentMember2021-01-312021-05-010000018498us-gaap:OperatingSegmentsMember2022-01-302022-04-300000018498us-gaap:TrademarksMember2022-04-300000018498country:GB2021-05-010000018498gco:RetailStoreAssetImpairmentsMembergco:SchuhGroupSegmentMember2022-01-302022-04-300000018498us-gaap:RevolvingCreditFacilityMembergco:USRevolverBorrowingsMember2022-04-300000018498gco:JohnstonAndMurphyGroupSegmentMemberus-gaap:IntersegmentEliminationMember2021-01-312021-05-010000018498us-gaap:IntersegmentEliminationMembergco:JourneysGroupSegmentMember2022-01-302022-04-300000018498gco:JohnstonAndMurphyGroupSegmentMember2021-01-312021-05-010000018498us-gaap:CustomerListsMember2022-01-290000018498us-gaap:FairValueInputsLevel1Member2022-04-300000018498us-gaap:CorporateNonSegmentMember2022-01-302022-04-300000018498gco:JourneysGroupSegmentMember2022-01-290000018498gco:RetailStoreAssetImpairmentsMembergco:JourneysGroupSegmentMember2022-01-302022-04-3000000184982022-04-300000018498us-gaap:PreferredStockMember2021-01-300000018498us-gaap:TreasuryStockMember2021-05-010000018498gco:LicensedBrandsSegmentMember2021-01-312021-05-010000018498gco:JourneysGroupSegmentMember2022-04-300000018498us-gaap:RevolvingCreditFacilityMembergco:USRevolverBorrowingsMember2022-01-290000018498gco:GainOnTheTerminationOfThePensionPlanMember2022-01-302022-04-300000018498us-gaap:CustomerListsMember2022-04-300000018498us-gaap:OperatingSegmentsMembergco:SchuhGroupSegmentMember2021-01-312021-05-010000018498us-gaap:RetainedEarningsMember2021-01-312021-05-010000018498us-gaap:OperatingSegmentsMembergco:JourneysGroupSegmentMember2022-04-300000018498us-gaap:PreferredStockMember2022-01-290000018498dei:FormerAddressMember2022-01-302022-04-3000000184982021-01-312021-05-010000018498us-gaap:CommonStockMember2021-01-312021-05-010000018498us-gaap:AdditionalPaidInCapitalMember2021-01-300000018498gco:LicensedBrandsSegmentMemberus-gaap:OperatingSegmentsMember2022-04-300000018498us-gaap:PreferredStockMember2022-04-300000018498us-gaap:CorporateNonSegmentMember2021-05-010000018498us-gaap:CommonStockMember2022-01-302022-04-300000018498gco:LicensedBrandsSegmentMemberus-gaap:IntersegmentEliminationMember2021-01-312021-05-010000018498gco:JourneysGroupSegmentMember2022-01-302022-04-300000018498gco:RetailStoreAssetImpairmentsMember2021-01-312021-05-010000018498gco:LicensedBrandsSegmentMemberus-gaap:IntersegmentEliminationMember2022-01-302022-04-3000000184982022-05-270000018498us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-300000018498gco:LicensedBrandsSegmentMemberus-gaap:OperatingSegmentsMember2021-01-312021-05-010000018498gco:LicensedBrandsSegmentMemberus-gaap:OperatingSegmentsMember2022-01-302022-04-3000000184982022-01-302022-04-300000018498country:CA2021-05-010000018498gco:LicensedBrandsSegmentMember2022-04-30iso4217:USDxbrli:sharesxbrli:sharesgco:Storegco:Segmentiso4217:USD
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
10-Q
(Mark One)
|
|
☒
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 For the Quarter Ended
April 30, 2022
|
|
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 for the transition period from to
|
Commission File No.
1-3083
Genesco Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
Tennessee
|
|
62-0211340
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
535 Marriott Drive
|
|
37214
|
Nashville,
|
Tennessee
|
|
(Zip Code)
|
(Address of principal executive offices)
|
|
|
Registrant's telephone number, including area code:
(615)
367-7000
Former address:
1415 Murfreesboro Pike,
Nashville,
Tennessee
37217-2895
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $1.00 par value
|
GCO
|
New York Stock Exchange
|
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such report), and (2) has been subject to such filing requirements
for the past 90 days.
Yes
☒
No
☐
Indicate by check mark whether the registrant has submitted
electronically every Interactive Data File required to be submitted
pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter)
during the preceding 12 months (or for such shorter period that the
registrant was required to submit such files).
Yes
☒
No
☐
Indicate by check mark whether the registrant is a large
accelerated filer; an accelerated filer; a non-accelerated filer; a
smaller reporting company; or an emerging growth company. See
definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company” and “emerging growth company” in Rule
12b-2 of the Exchange Act:
|
|
|
|
|
|
Large accelerated filer
|
|
☒
|
|
Accelerated filer
|
☐
|
|
|
|
|
Non-accelerated filer
|
|
☐
|
|
Smaller reporting company
|
☐
|
|
|
|
|
Emerging growth company
|
|
☐
|
|
|
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act.
☐
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act) Yes
☐
No
☒
As of May 27, 2022, there were
13,728,784
shares of the registrant's common stock outstanding.
INDEX
|
|
|
|
Part I. Financial Information
|
|
Item 1. Financial Statements (unaudited):
|
|
Condensed Consolidated Balance Sheets - April 30, 2022, January 29,
2022 and May 1, 2021
|
4
|
Condensed Consolidated Statements of Operations - Three Months
ended April 30, 2022 and May 1, 2021
|
5
|
Condensed Consolidated Statements of Comprehensive Income - Three
Months ended April 30, 2022 and May 1, 2021
|
6
|
Condensed Consolidated Statements of Cash Flows - Three Months
ended April 30, 2022 and May 1, 2021
|
7
|
Condensed Consolidated Statements of Equity - Three Months ended
April 30, 2022 and May 1, 2021
|
8
|
Notes to Condensed Consolidated Financial Statements
(unaudited)
|
9
|
Item 2. Management's Discussion and Analysis of Financial Condition
and Results of Operations
|
15
|
Item 3. Quantitative and Qualitative Disclosures about Market
Risk
|
21
|
Item 4. Controls and Procedures
|
21
|
Part II. Other Information
|
22
|
Item 1. Legal Proceedings
|
22
|
Item 1A. Risk Factors
|
22
|
Item 2. Unregistered Sales of Equity Securities and Use of
Proceeds
|
22
|
Item 6. Exhibits
|
23
|
Signature
|
24
|
|
|
2
cautionary notice regarding forward-looking statements
Statements in this Quarterly Report on Form 10-Q include certain
forward-looking statements, which include statements regarding our
intent, belief or expectations and all statements other than those
made solely with respect to historical fact. Actual results could
differ materially from those reflected by the forward-looking
statements in this Quarterly Report on Form 10-Q and a number of
factors may adversely affect the forward-looking statements and our
future results, liquidity, capital resources or prospects. These
include, but are not limited to, risks related to public health and
safety issues, including, for example, risks related to the ongoing
novel coronavirus ("COVID-19") pandemic; disruptions to our
business, sales, supply chain and financial results; the level of
consumer spending on our merchandise and interest in our brands and
in general, the level and timing of promotional activity necessary
to maintain inventories at appropriate levels; our ability to pass
on price increases to our customers; the timing and amount of any
share repurchases by us; risks related to doing business
internationally, including the manufacturing of a portion of our
products in China; the imposition of tariffs on products imported
by us or our vendors as well as the ability and costs to move
production of products in response to tariffs; our ability to
obtain from suppliers products that are in-demand on a timely basis
and effectively manage disruptions in product supply or
distribution; unfavorable trends in fuel costs, foreign exchange
rates, foreign labor and material costs; a disruption in shipping
or increase in cost of our imported products, and other factors
affecting the cost of products; our dependence on third-party
vendors and licensors for the products we sell; the effects of the
withdrawal of the United Kingdom ("U.K.") from the European Union
("Brexit") and other sources of market weakness in the U.K. and the
Republic of Ireland (the “ROI”); the effectiveness of our
omnichannel initiatives; costs associated with changes in minimum
wage and overtime requirements; wage pressure in the U.S. and the
U.K.; labor shortages; the effects of inflation, including our
ability to pass increased cost on to consumers; effects resulting
from wars and other military operations; the evolving regulatory
landscape related to our use of social media; the establishment and
protection of our intellectual property; weakness in the consumer
economy and retail industry; competition and fashion trends in our
markets, including trends with respect to the popularity of casual
and dress footwear; weakness in shopping mall traffic; any failure
to increase sales at our existing stores, given our high fixed
expense cost structure, and in our e-commerce businesses; risks
related to the potential for terrorist events; changes in buying
patterns by significant wholesale customers; changes in consumer
preferences; our ability to continue to complete and integrate
acquisitions; our ability to expand our business and diversify our
product base; impairment of goodwill in connection with
acquisitions; payment related risks that could increase our
operating cost, expose us to fraud or theft, subject us to
potential liability and disrupt our business; retained liabilities
associated with divestitures of businesses including potential
liabilities under leases as the prior tenant or as a guarantor of
certain leases; and changes in the timing of holidays or in the
onset of seasonal weather affecting period-to-period sales
comparisons. Additional factors that could cause differences from
expectations include our ability to open additional retail stores,
renew leases in existing stores, control or lower occupancy costs,
to conduct required remodeling or refurbishment on schedule and at
expected expense levels; realize anticipated cost savings,
including rent savings; realize any anticipated tax benefits, and
achieve expected digital gains and gain market share; deterioration
in the performance of individual businesses or of our market value
relative to our book value, resulting in impairments of fixed
assets, operating lease right of use assets or intangible assets or
other adverse financial consequences and the timing and amount of
such impairments or other consequences; unexpected changes to the
market for our shares or for the retail sector in general; costs
and reputational harm as a result of disruptions in our business or
information technology systems either by security breaches and
incidents or by potential problems associated with the
implementation of new or upgraded systems, and the cost and outcome
of litigation, investigations and environmental matters that
involve us. For a full discussion of risk factors, see Item 1A,
"Risk Factors".
Readers are cautioned not to place undue reliance on
forward-looking statements as such statements speak only as of the
date they were made and involve risks and uncertainties that could
cause actual events or results to differ materially from the events
or results described in the forward-looking statements. The most
important factors which could cause our actual results to differ
from our forward-looking statements are set forth in our
description of risk factors in Item 1A
contained in our Annual Report on Form 10-K for the fiscal year
ended January 29, 2022,
which should be read in conjunction with the forward-looking
statements in this Quarterly Report on Form 10-Q. Forward-looking
statements speak only as of the date they are made, and we do not
undertake any obligation to update any forward-looking
statement.
The events described in the forward-looking statements might not
occur or might occur to a different extent or at a different time
than we have described. As a result, our actual results may differ
materially from the results contemplated by these forward-looking
statements.
We maintain a website at
www.genesco.com
where investors and other interested parties may obtain, free of
charge, press releases and other information as well as gain access
to our periodic filings with the Securities and Exchange Commission
(“SEC”). The information contained on this website should not be
considered to be a part of this or any other report filed with or
furnished to the SEC.
3
PART I - FINANCIAL
INFORMATION
Item 1. Financial Statements
(unaudited)
Genesco Inc. and Subsidiaries
Condensed Consolidated
Balance Sheets
(In thousands, except share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets
|
|
April 30, 2022
|
|
|
January 29, 2022
|
|
|
May 1, 2021
|
|
Current Assets:
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
200,623
|
|
|
$
|
320,525
|
|
|
$
|
258,044
|
|
Accounts receivable, net of allowances of $5,074 at
April 30, 2022,
|
|
|
|
|
|
|
|
|
|
$4,656 at
January 29, 2022 and $4,474 at
May 1, 2021
|
|
|
48,868
|
|
|
|
39,509
|
|
|
|
45,891
|
|
Inventories
|
|
|
401,479
|
|
|
|
278,200
|
|
|
|
301,017
|
|
Prepaids and other current assets
|
|
|
74,609
|
|
|
|
71,564
|
|
|
|
117,467
|
|
Total current assets
|
|
|
725,579
|
|
|
|
709,798
|
|
|
|
722,419
|
|
Property and equipment, net
|
|
|
219,421
|
|
|
|
216,308
|
|
|
|
208,759
|
|
Operating lease right of use assets
|
|
|
508,986
|
|
|
|
543,789
|
|
|
|
639,575
|
|
Goodwill
|
|
|
38,487
|
|
|
|
38,556
|
|
|
|
38,944
|
|
Other intangibles
|
|
|
28,298
|
|
|
|
29,855
|
|
|
|
31,112
|
|
Deferred income taxes
|
|
|
4,269
|
|
|
|
1,466
|
|
|
|
—
|
|
Other noncurrent assets
|
|
|
23,402
|
|
|
|
22,327
|
|
|
|
21,558
|
|
Total Assets
|
|
|
1,548,442
|
|
|
|
1,562,099
|
|
|
|
1,662,367
|
|
Liabilities and Equity
|
|
|
|
|
|
|
|
|
|
Current Liabilities:
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
|
243,224
|
|
|
|
152,484
|
|
|
|
164,975
|
|
Current portion - operating lease liabilities
|
|
|
137,770
|
|
|
|
145,088
|
|
|
|
158,295
|
|
Other accrued liabilities
|
|
|
83,882
|
|
|
|
134,156
|
|
|
|
112,648
|
|
Total current liabilities
|
|
|
464,876
|
|
|
|
431,728
|
|
|
|
435,918
|
|
Long-term debt
|
|
|
14,712
|
|
|
|
15,679
|
|
|
|
44,169
|
|
Long-term operating lease liabilities
|
|
|
430,606
|
|
|
|
471,878
|
|
|
|
555,204
|
|
Other long-term liabilities
|
|
|
37,910
|
|
|
|
40,346
|
|
|
|
48,068
|
|
Total liabilities
|
|
|
948,104
|
|
|
|
959,631
|
|
|
|
1,083,359
|
|
Commitments and contingent
liabilities
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
Non-redeemable preferred stock
|
|
|
818
|
|
|
|
827
|
|
|
|
828
|
|
Common equity:
|
|
|
|
|
|
|
|
|
|
Common stock, $1 par
value:
|
|
|
|
|
|
|
|
|
|
Authorized:
80,000,000 shares
|
|
|
|
|
|
|
|
|
|
Issued common stock
|
|
|
14,217
|
|
|
|
14,256
|
|
|
|
15,444
|
|
Additional paid-in capital
|
|
|
294,628
|
|
|
|
291,444
|
|
|
|
284,396
|
|
Retained earnings
|
|
|
348,757
|
|
|
|
350,206
|
|
|
|
329,798
|
|
Accumulated other comprehensive loss
|
|
|
(40,225
|
)
|
|
|
(36,408
|
)
|
|
|
(33,601
|
)
|
Treasury shares, at cost (488,464 shares)
|
|
|
(17,857
|
)
|
|
|
(17,857
|
)
|
|
|
(17,857
|
)
|
Total equity
|
|
|
600,338
|
|
|
|
602,468
|
|
|
|
579,008
|
|
Total Liabilities and Equity
|
|
$
|
1,548,442
|
|
|
$
|
1,562,099
|
|
|
$
|
1,662,367
|
|
The accompanying Notes are an integral part of these Condensed
Consolidated Financial Statements.
4
Genesco Inc. and Subsidiaries
Condensed Consolidated Statements
of Operations
(In thousands, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
|
April 30, 2022
|
|
|
May 1, 2021
|
|
|
Net sales
|
|
$
|
520,748
|
|
|
$
|
538,695
|
|
|
Cost of sales
|
|
|
269,304
|
|
|
|
281,033
|
|
|
Gross margin
|
|
|
251,444
|
|
|
|
257,662
|
|
|
Selling and administrative expenses
|
|
|
243,481
|
|
|
|
239,465
|
|
|
Asset impairments and other, net
|
|
|
(283
|
)
|
|
|
2,670
|
|
|
Operating income
|
|
|
8,246
|
|
|
|
15,527
|
|
|
Other components of net periodic benefit cost (income)
|
|
|
98
|
|
|
|
(39
|
)
|
|
Interest expense (net of interest income of $0.1 million
for each of the three months ended April 30, 2022 and May 1,
2021)
|
|
|
297
|
|
|
|
729
|
|
|
Earnings from continuing operations before income taxes
|
|
|
7,851
|
|
|
|
14,837
|
|
|
Income tax expense
|
|
|
2,882
|
|
|
|
5,943
|
|
|
Earnings from continuing operations
|
|
|
4,969
|
|
|
|
8,894
|
|
|
Loss from discontinued operations, net of tax
|
|
|
(22
|
)
|
|
|
(16
|
)
|
|
Net Earnings
|
|
$
|
4,947
|
|
|
$
|
8,878
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share:
|
|
|
|
|
|
|
|
Continuing operations
|
|
$
|
0.38
|
|
|
$
|
0.62
|
|
|
Discontinued operations
|
|
|
0.00
|
|
|
|
0.00
|
|
|
Net earnings
|
|
$
|
0.38
|
|
|
$
|
0.62
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per common share:
|
|
|
|
|
|
|
|
Continuing operations
|
|
$
|
0.37
|
|
|
$
|
0.60
|
|
|
Discontinued operations
|
|
|
0.00
|
|
|
|
0.00
|
|
|
Net earnings
|
|
$
|
0.37
|
|
|
$
|
0.60
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding:
|
|
|
|
|
|
|
|
Basic
|
|
|
12,961
|
|
|
|
14,287
|
|
|
Diluted
|
|
|
13,369
|
|
|
|
14,702
|
|
|
The accompanying Notes are an integral part of these Condensed
Consolidated Financial Statements.
5
Genesco Inc. and Subsidiaries
Condensed Consolidated Statements
of Comprehensive Income
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
|
April 30, 2022
|
|
|
May 1, 2021
|
|
|
Net earnings
|
|
$
|
4,947
|
|
|
$
|
8,878
|
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
Postretirement liability adjustments, net of tax
|
|
|
50
|
|
|
|
(44
|
)
|
|
Foreign currency translation adjustments
|
|
|
(3,867
|
)
|
|
|
1,502
|
|
|
Total other comprehensive income (loss)
|
|
|
(3,817
|
)
|
|
|
1,458
|
|
|
Comprehensive Income
|
|
$
|
1,130
|
|
|
$
|
10,336
|
|
|
The accompanying Notes are an integral part of these Condensed
Consolidated Financial Statements.
6
Genesco Inc. and Subsidiaries
Condensed Consolidated Statements
of Cash Flows
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
April 30, 2022
|
|
|
May 1, 2021
|
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
|
|
Net earnings
|
|
$
|
4,947
|
|
|
$
|
8,878
|
|
Adjustments to reconcile net earnings to net cash provided by (used
in)
|
|
|
|
|
|
|
operating activities:
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
10,551
|
|
|
|
10,889
|
|
Deferred income taxes
|
|
|
(2,820
|
)
|
|
|
(10,054
|
)
|
Impairment of long-lived assets
|
|
|
413
|
|
|
|
414
|
|
Share-based compensation expense
|
|
|
3,239
|
|
|
|
1,912
|
|
Other
|
|
|
499
|
|
|
|
149
|
|
Changes in working capital and other assets and liabilities, net
of
acquisitions/dispositions:
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(9,977
|
)
|
|
|
(14,186
|
)
|
Inventories
|
|
|
(126,674
|
)
|
|
|
(9,031
|
)
|
Prepaids and other current assets
|
|
|
(3,490
|
)
|
|
|
12,719
|
|
Accounts payable
|
|
|
92,061
|
|
|
|
14,784
|
|
Other accrued liabilities
|
|
|
(44,194
|
)
|
|
|
33,832
|
|
Other assets and liabilities
|
|
|
(16,622
|
)
|
|
|
(6,120
|
)
|
Net cash provided by (used in) operating activities
|
|
|
(92,067
|
)
|
|
|
44,186
|
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
|
|
Capital expenditures
|
|
|
(15,397
|
)
|
|
|
(12,102
|
)
|
Net cash used in investing activities
|
|
|
(15,397
|
)
|
|
|
(12,102
|
)
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
|
Borrowings under revolving credit facility
|
|
|
2,609
|
|
|
|
15,736
|
|
Payments on revolving credit facility
|
|
|
(2,609
|
)
|
|
|
(4,678
|
)
|
Shares repurchased related to share repurchase plan
|
|
|
(11,280
|
)
|
|
|
—
|
|
Change in overdraft balances
|
|
|
—
|
|
|
|
(533
|
)
|
Other
|
|
|
(2
|
)
|
|
|
(35
|
)
|
Net cash provided by (used in) financing activities
|
|
|
(11,282
|
)
|
|
|
10,490
|
|
Effect of foreign exchange rate fluctuations on cash
|
|
|
(1,156
|
)
|
|
|
379
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
(119,902
|
)
|
|
|
42,953
|
|
Cash and cash equivalents at beginning of period
|
|
|
320,525
|
|
|
|
215,091
|
|
Cash and cash equivalents at end of period
|
|
$
|
200,623
|
|
|
$
|
258,044
|
|
Supplemental information:
|
|
|
|
|
|
|
Interest paid
|
|
$
|
327
|
|
|
$
|
538
|
|
Income taxes paid
|
|
|
225
|
|
|
|
127
|
|
Cash paid for amounts included in measurement of operating lease
liabilities
|
|
|
57,278
|
|
|
|
45,532
|
|
Operating lease assets obtained in exchange for new operating lease
liabilities
|
|
|
13,935
|
|
|
|
54,247
|
|
The accompanying Notes are an integral part of these Condensed
Consolidated Financial Statements.
7
Genesco Inc. and Subsidiaries
Condensed Consolidated
Statements of Equity
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-
Redeemable
Preferred
Stock
|
|
Common
Stock
|
|
Additional
Paid-In
Capital
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Loss
|
|
Treasury
Shares
|
|
Total
Equity
|
|
Balance January 30, 2021
|
$
|
1,009
|
|
$
|
15,438
|
|
$
|
282,308
|
|
$
|
320,920
|
|
$
|
(35,059
|
)
|
$
|
(17,857
|
)
|
$
|
566,759
|
|
Net earnings
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8,878
|
|
|
—
|
|
|
—
|
|
|
8,878
|
|
Other comprehensive income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,458
|
|
|
—
|
|
|
1,458
|
|
Share-based compensation expense
|
|
—
|
|
|
—
|
|
|
1,912
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,912
|
|
Other
|
|
(181
|
)
|
|
6
|
|
|
176
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
Balance May 1, 2021
|
$
|
828
|
|
$
|
15,444
|
|
$
|
284,396
|
|
$
|
329,798
|
|
$
|
(33,601
|
)
|
$
|
(17,857
|
)
|
$
|
579,008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-
Redeemable
Preferred
Stock
|
|
Common
Stock
|
|
Additional
Paid-In
Capital
|
|
Retained
Earnings
|
|
Accumulated
Other
Comprehensive
Loss
|
|
Treasury
Shares
|
|
Total
Equity
|
|
Balance January 29, 2022
|
$
|
827
|
|
$
|
14,256
|
|
$
|
291,444
|
|
$
|
350,206
|
|
$
|
(36,408
|
)
|
$
|
(17,857
|
)
|
$
|
602,468
|
|
Net earnings
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,947
|
|
|
—
|
|
|
—
|
|
|
4,947
|
|
Other comprehensive loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,817
|
)
|
|
—
|
|
|
(3,817
|
)
|
Share-based compensation expense
|
|
—
|
|
|
—
|
|
|
3,239
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,239
|
|
Restricted stock issuance
|
|
—
|
|
|
78
|
|
|
(78
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Shares repurchased
|
|
—
|
|
|
(104
|
)
|
|
—
|
|
|
(6,396
|
)
|
|
—
|
|
|
—
|
|
|
(6,500
|
)
|
Other
|
|
(9
|
)
|
|
(13
|
)
|
|
23
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
Balance April 30, 2022
|
$
|
818
|
|
$
|
14,217
|
|
$
|
294,628
|
|
$
|
348,757
|
|
$
|
(40,225
|
)
|
$
|
(17,857
|
)
|
$
|
600,338
|
|
The accompanying Notes are an integral part of these Condensed
Consolidated Financial Statements.
8
Genesco Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(unaudited)
Note 1
Summary of Significant
Accounting Policies
Basis of Presentation
The Condensed Consolidated Financial Statements and Notes contained
in this report are unaudited but reflect all adjustments, including
normal recurring adjustments, necessary for a fair presentation of
the results for the interim periods of the fiscal year ending
January 28, 2023 ("Fiscal 2023") and of the fiscal year ended
January 29, 2022 ("Fiscal 2022"). All subsidiaries are consolidated
in the Condensed Consolidated Financial Statements. All significant
intercompany transactions and accounts have been eliminated. The
results of operations for any interim period are not necessarily
indicative of results for the full year. The Condensed Consolidated
Financial Statements and the related Notes have been prepared in
accordance with the instructions to Form 10-Q and do not include
all of the information and footnotes required by U.S. Generally
Accepted Accounting Principles (“GAAP”) for complete financial
statements.
The Condensed Consolidated Balance Sheet as of January 29, 2022 has
been derived from the audited financial statements at that date.
These Condensed Consolidated Financial Statements should be read in
conjunction with our Consolidated Financial Statements and Notes
for Fiscal 2022, which are contained in our Annual Report on Form
10-K as filed with the SEC on March 23, 2022.
Nature of Operations
Genesco Inc. and its subsidiaries (collectively the "Company",
"Genesco," "we", "our", or "us") business includes the sourcing and
design, marketing and distribution of footwear and accessories
through retail stores in the U.S., Puerto Rico and Canada primarily
under the Journeys®,
Journeys Kidz®,
Little Burgundy®
and Johnston & Murphy®
banners and under the Schuh®
banner in the United Kingdom (“U.K.”) and the Republic of Ireland
(“ROI”); through catalogs and e-commerce websites including the
following: journeys.com, journeyskidz.com, journeys.ca,
littleburgundyshoes.com, schuh.co.uk, schuh.ie, schuh.eu,
johnstonmurphy.com, johnstonmurphy.ca, nashvillewarehouse.com and
dockersshoes.com and at wholesale, primarily under our Johnston
& Murphy brand, the licensed Levi's®
brand, the licensed Dockers®
brand, the licensed G.H. Bass®
brand and other brands that we license for footwear. At April 30,
2022, we operated
1,414
retail stores in the U.S., Puerto Rico, Canada, the U.K. and the
ROI.
During the three months ended April 30, 2022 and May 1, 2021, we
operated
four
reportable business segments (not including corporate): (i)
Journeys Group, comprised of the Journeys, Journeys Kidz and Little
Burgundy retail footwear chains and e-commerce operations; (ii)
Schuh Group, comprised of the Schuh retail footwear chain and
e-commerce operations; (iii) Johnston & Murphy Group, comprised
of Johnston & Murphy retail operations, e-commerce operations
and wholesale distribution of products under the Johnston &
Murphy brand; and (iv) Licensed Brands, comprised of the licensed
Dockers, Levi's, and G.H. Bass brands, as well as other brands we
license for footwear.
Cash and Cash Equivalents
There were cash equivalents of
$95.0
million as of April 30, 2022. There were
no
cash equivalents as of January 29, 2022 or May 1, 2021. Our
$95.0
million of cash equivalents at April 30, 2022 were invested in
institutional money market funds which invest exclusively in highly
rated, short-term securities that are issued, guaranteed or
collateralized by the U.S. government or by U.S. government
agencies and instrumentalities. Due to their short-term nature, the
carrying amounts reported in the Condensed Consolidated Balance
Sheets approximate the fair value of cash and cash
equivalents.
Selling and Administrative Expenses
Wholesale costs of distribution are included in selling and
administrative expenses on the Condensed Consolidated Statements of
Operations in the amount of
$2.7
million and
$3.6
million for the first quarters of Fiscal 2023 and Fiscal 2022,
respectively.
Retail occupancy costs recorded in selling and administrative
expense were
$78.5
million and
$70.8
million for the first quarters of Fiscal 2023 and Fiscal 2022,
respectively.
Advertising Costs
Advertising costs were
$22.1
million and
$21.1
million for the first quarters of Fiscal 2023 and Fiscal 2022,
respectively.
9
Genesco Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(unaudited)
Note 1
Summary of Significant Accounting Policies, Continued
Vendor Allowances
Vendor reimbursements of cooperative advertising costs recognized
as a reduction of selling and administrative expenses were
$3.2
million and
$3.0
million for the first quarters of Fiscal 2023 and Fiscal 2022,
respectively. During the first three months of each of Fiscal 2023
and Fiscal 2022, our cooperative advertising reimbursements
received were not in excess of the costs incurred.
COVID-19 Pandemic
The COVID-19 pandemic has created significant public health
concerns as well as economic disruption, uncertainty, and
volatility which may negatively affect our business operations. As
a result, if the pandemic persists or worsens, our accounting
estimates and assumptions could be impacted in subsequent interim
reports and upon final determination at year-end, and it is
reasonably possible such changes could be significant.
New Accounting Pronouncements
We do not currently have any new accounting pronouncements pending
adoption.
Note 2
Goodwill and Other Intangible Assets
The changes in the carrying amount of goodwill by segment were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands)
|
|
Journeys
Group
|
|
|
Licensed
Brands
Group
|
|
|
Total
Goodwill
|
|
Balance, January 29, 2022
|
|
$
|
10,087
|
|
|
$
|
28,469
|
|
|
$
|
38,556
|
|
Effect of foreign currency exchange rates
|
|
|
(65
|
)
|
|
|
(4
|
)
|
|
|
(69
|
)
|
Balance, April 30, 2022
|
|
$
|
10,022
|
|
|
$
|
28,465
|
|
|
$
|
38,487
|
|
Other intangibles by major classes were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trademarks
|
|
Customer Lists
|
|
|
Other
|
|
|
Total
|
|
(In thousands)
|
|
Apr. 30, 2022
|
|
|
Jan. 29,
2022
|
|
Apr. 30, 2022
|
|
|
Jan. 29,
2022
|
|
|
Apr. 30, 2022
|
|
|
Jan. 29,
2022
|
|
|
Apr. 30, 2022
|
|
|
Jan. 29,
2022
|
|
Gross other intangibles
|
|
$
|
24,521
|
|
|
$
|
25,935
|
|
$
|
6,498
|
|
|
$
|
6,586
|
|
|
$
|
400
|
|
|
$
|
400
|
|
|
$
|
31,419
|
|
|
$
|
32,921
|
|
Accumulated amortization
|
|
|
—
|
|
|
|
—
|
|
|
(2,721
|
)
|
|
|
(2,666
|
)
|
|
|
(400
|
)
|
|
|
(400
|
)
|
|
|
(3,121
|
)
|
|
|
(3,066
|
)
|
Net Other Intangibles
|
|
$
|
24,521
|
|
|
$
|
25,935
|
|
$
|
3,777
|
|
|
$
|
3,920
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
28,298
|
|
|
$
|
29,855
|
|
Note 3
Asset Impairments and Other Charges
We recorded a pretax gain of
$0.3
million in the first quarter of Fiscal 2023, including a gain
of
$0.7
million for the pension plan termination, partially offset
by
$0.4
million for retail store asset impairments.
We recorded pretax charges of
$2.7
million in the first quarter of Fiscal 2022, including
$2.3
million for professional fees related to actions of an activist
shareholder and
$0.4
for retail store asset impairments.
10
Genesco Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(unaudited)
Note 4
Inventories and Other Current Accrued Liabilities
Inventory
|
|
|
|
|
|
|
|
|
(In thousands)
|
|
April 30, 2022
|
|
|
January 29, 2022
|
|
Wholesale finished goods
|
|
$
|
40,078
|
|
|
$
|
28,432
|
|
Retail merchandise
|
|
|
361,401
|
|
|
|
249,768
|
|
Total Inventories
|
|
$
|
401,479
|
|
|
$
|
278,200
|
|
Other Current Accrued Liabilities
|
|
|
|
|
|
|
(In thousands)
|
April 30, 2022
|
|
January 29, 2022
|
|
Accrued employee compensation(1)
|
$
|
16,887
|
|
$
|
60,575
|
|
Accrued other taxes
|
|
14,918
|
|
|
17,631
|
|
Accrued income taxes
|
|
1,640
|
|
|
2,385
|
|
Provision for discontinued operations
|
|
486
|
|
|
491
|
|
Other accrued liabilities
|
|
49,951
|
|
|
53,074
|
|
Total Other Current Accrued Liabilities
|
$
|
83,882
|
|
$
|
134,156
|
|
(1)
The accrual for performance-based incentive compensation of
$48.1
million as of January 29, 2022 was paid in the first quarter of
Fiscal 2023.
Note 5
Fair Value
Fair Value of Financial Instruments
The carrying amounts and fair values of our financial instruments
at April 30, 2022 and January 29, 2022 are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Values
|
|
|
|
(In thousands)
|
|
April 30, 2022
|
|
|
January 29, 2022
|
|
|
|
Carrying
Amount
|
|
|
Fair
Value
|
|
|
Carrying
Amount
|
|
|
Fair
Value
|
|
U.S. Revolver Borrowings
|
|
$
|
14,712
|
|
|
$
|
14,679
|
|
|
$
|
15,679
|
|
|
$
|
15,679
|
|
Debt fair values were determined using a discounted cash flow
analysis based on current market interest rates for similar types
of financial instruments and would be classified in Level 2 within
the fair value hierarchy.
As of April 30, 2022, we have
$3.5
million of long-lived assets held and used which were measured
using Level 3 inputs within the fair value hierarchy. As of April
30, 2022, we have
$11.1
million of investments held and used which were measured using
Level 1 inputs within the fair value hierarchy.
11
Genesco Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(unaudited)
Note 6
Earnings Per Share
Weighted-average number of shares used to calculate earnings per
share are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
(Shares in thousands)
|
|
April 30, 2022
|
|
|
May 1, 2021
|
|
|
Weighted-average number of shares - basic
|
|
|
12,961
|
|
|
|
14,287
|
|
|
Common stock equivalents
|
|
|
408
|
|
|
|
415
|
|
|
Weighted-average number of shares - diluted
|
|
|
13,369
|
|
|
|
14,702
|
|
|
We repurchased
102,895
shares during the first quarter of Fiscal 2023 at a cost of
$6.5
million, or
$63.17
per share. We accrued
$4.8
million of share repurchases in the fourth quarter of Fiscal 2022
due to timing of the cash settlement and it is included on the
Condensed Consolidated Statements of Cash Flows for the three
months ended April 30, 2022. We have
$100.3
million remaining as of April 30, 2022 under our expanded share
repurchase authorization announced in February 2022. We did
not
repurchase any shares during the first quarter of Fiscal 2022.
During the second quarter of Fiscal 2023, through June 8, 2022, we
have repurchased
175,000
shares at a cost of
$10.1
million, or
$57.94
per share.
Note 7
Long-Term Debt
|
|
|
|
|
|
|
|
|
(In thousands)
|
|
April 30, 2022
|
|
|
January 29, 2022
|
|
U.S. revolver borrowings
|
|
$
|
14,712
|
|
|
$
|
15,679
|
|
Total long-term debt
|
|
|
14,712
|
|
|
|
15,679
|
|
Current portion
|
|
|
—
|
|
|
|
—
|
|
Total Noncurrent Portion of Long-Term Debt
|
|
$
|
14,712
|
|
|
$
|
15,679
|
|
We were in compliance with all the relevant terms and conditions of
the Credit Facility and Facility Letter as of April 30,
2022.
Note 8
Legal Proceedings
Environmental Matters
The Company has legacy obligations including environmental
monitoring and reporting costs related to: (i) a 2016 Consent
Judgment entered into with the United States Environmental
Protection Agency involving the site of a knitting mill operated by
a former subsidiary of ours from 1965 to 1969 in Garden City, New
York; and (ii) a 2010 Consent Decree with the Michigan Department
of Natural Resources and Environment relating to our former
Volunteer Leather Company facility in Whitehall, Michigan. We do
not expect that future obligations related to either of these sites
will have a material effect on our financial condition or results
of operations.
Accrual for Environmental Contingencies
Related to all outstanding environmental contingencies, we had
accrued
$1.4
million as of each of April 30, 2022, January 29, 2022 and May 1,
2021. All such provisions reflect our estimates of the most likely
cost (undiscounted, including both current and noncurrent portions)
of resolving the contingencies, based on facts and circumstances as
of the time they were made. There is no assurance that relevant
facts and circumstances will not change, necessitating future
changes to the provisions. Such contingent liabilities are included
in the liability arising from provision for discontinued operations
on the accompanying Condensed Consolidated Balance Sheets because
they relate to former facilities operated by us. We have made
pretax accruals for certain of these contingencies which were not
material for the first three months of Fiscal 2023 or Fiscal 2022.
These charges are included in loss from discontinued operations,
net in the Condensed Consolidated Statements of Operations and
represent changes in estimates.
In addition to the matters specifically described in this Note, we
are a party to other legal and regulatory proceedings and claims
arising in the ordinary course of our business. While management
does not believe that our liability with respect to any of these
other matters is likely to have a material effect on our financial
statements, legal proceedings are subject to inherent
uncertainties, and unfavorable rulings could have a material
adverse impact on our financial statements.
12
Genesco Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(unaudited)
As part of our Licensed Brands business, we have a commitment to
Samsung C&T America, Inc. (“Samsung”) related to the ultimate
sale and valuation of inventories owned by Samsung. If product is
sold below Samsung’s cost, we are required to pay to Samsung the
difference between the sales price and its cost. At April 30, 2022,
the inventory owned by Samsung had a historical cost of
$16.7
million.
Note 10
Business Segment Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended April 30, 2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In
thousands)
|
|
Journeys
Group
|
|
|
Schuh
Group
|
|
|
Johnston
& Murphy
Group
|
|
|
Licensed
Brands
|
|
|
Corporate
& Other
|
|
|
Consolidated
|
|
Sales
|
|
$
|
314,445
|
|
|
$
|
88,159
|
|
|
$
|
71,016
|
|
|
$
|
47,900
|
|
|
$
|
—
|
|
|
$
|
521,520
|
|
Intercompany sales
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(772
|
)
|
|
|
—
|
|
|
|
(772
|
)
|
Net sales to external customers
|
|
$
|
314,445
|
|
|
$
|
88,159
|
|
|
$
|
71,016
|
|
|
$
|
47,128
|
|
|
$
|
—
|
|
|
$
|
520,748
|
|
Segment operating income (loss)
|
|
$
|
14,930
|
|
|
$
|
(2,746
|
)
|
|
$
|
550
|
|
|
$
|
3,793
|
|
|
$
|
(8,564
|
)
|
|
$
|
7,963
|
|
Asset impairments and other
(1)
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
283
|
|
|
|
283
|
|
Operating income (loss)
|
|
|
14,930
|
|
|
|
(2,746
|
)
|
|
|
550
|
|
|
|
3,793
|
|
|
|
(8,281
|
)
|
|
|
8,246
|
|
Other components of net periodic benefit cost
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(98
|
)
|
|
|
(98
|
)
|
Interest expense, net
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(297
|
)
|
|
|
(297
|
)
|
Earnings (loss) from continuing operations before income
taxes
|
|
$
|
14,930
|
|
|
$
|
(2,746
|
)
|
|
$
|
550
|
|
|
$
|
3,793
|
|
|
$
|
(8,676
|
)
|
|
$
|
7,851
|
|
Total assets
(2)
|
|
$
|
766,780
|
|
|
$
|
195,591
|
|
|
$
|
146,914
|
|
|
$
|
72,114
|
|
|
$
|
367,043
|
|
|
$
|
1,548,442
|
|
Depreciation and amortization |